| Literature DB >> 30430767 |
Robert H Coker1, Melynda S Coker2, Larry Bartlett3, Carl J Murphy4, Karolina Priebe1, Timothy C Shriver4, Dale A Schoeller4, Brent C Ruby5.
Abstract
The purported healthy aspects of subsistence foods have led to the popularity of the Paleo diet. There has been very little focus, surprisingly, on health benefits derived from the nomadic nature of humans during the Paleolithic era. The purpose of our study was to examine total energy expenditure (TEE), total energy intake (TEI), body composition, blood lipids, and intrahepatic lipid in humans during a 12-day Alaskan backcountry expeditionary hunting (ABEH) immersion. Four healthy men (age: 42 ± 3 year, BMI: 27 ± 1 kg/m2 ) were recruited for the study. TEE was measured using the doubly labeled water method and a food diary was utilized to assess TEI. Body composition was measured using dual energy X-ray absorptiometry (DXA); cross-sectional area of the thigh (XT) and intrahepatic lipid (IHL) were measured using molecular imaging. Blood samples were collected for the measurement of blood lipids. DXA, XT, IHL, and blood data were collected pre- and immediately post-ABEH. Results were analyzed using paired t-tests and considered significant at P < 0.05. TEE and TEI averaged 18.1 ± 1.2 and 9.1 ± 2.5 MJ/day, respectively, indicating substantial negative energy balance (-9.0 ± 1.3 MJ/day). There was a reduction in percent body fat (∆-3.3 ± 0.2%), total fat mass (∆-3.3 ± 0.4 kg), and visceral fat volume (Δ-261 ± 188 cm3 ). Lean tissue mass and XT was unchanged. There was a decrease in IHL (Δ-0.5 ± 0.1% water peak), and a trend (P = 0.055) toward reduction in LDL-cholesterol. We conclude that constancy of physical activity during negative energy balance may provide metabolic benefits above and beyond variations in diet that exist with the hunter-gatherer lifestyle.Entities:
Keywords: Body composition; energy expenditure; hunter-gatherer; intrahepatic lipid
Mesh:
Substances:
Year: 2018 PMID: 30430767 PMCID: PMC6236107 DOI: 10.14814/phy2.13925
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Total energy expenditure and total energy intake in participant #1 from Alaska and participant #4 from the Mountain West. Data are presented as mean values for participant #1 and #4.
Isotope dosing and sample collection protocol
| Participant #1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Day | −1 | 0 | 2 | 3 | 7 | 10 | 13 | 13 | 14 |
| Collection times | 17:45 | 05:40 | 06:25 | 07:15 | 06:00 | 06:30 | 06:15 | 21:30 | 06:30 |
| Dose information | |||||||||
|
0.39 g H2
18O, 0.23 g 2H2O/kg TBW | * | ||||||||
| Urine sampling | |||||||||
| Background | * | ||||||||
| First void | * | * | * | * | * | * | |||
|
Second void | * | * | |||||||
Anthropometrics and fitness
| Pre | Post | ∆ | |
|---|---|---|---|
| Weight | |||
| #1 | 89.5 | 87.0 | −2.5 |
| #2 | 85.0 | 83.0 | −2.0 |
| #3 | 105.9 | 101.8 | −4.1 |
| #4 | 93.3 | 89.5 | −3.8 |
| Mean ± SD | 93.5 ± 7.8 | 90.3 ± 7.0 | −3.1 ± 0.9 |
| Body mass index (kg/m2) | |||
| #1 | 26.4 | 26.4 | 0.0 |
| #2 | 27.3 | 26.6 | −0.6 |
| #3 | 29.0 | 27.9 | −1.1 |
| #4 | 26.3 | 25.2 | −1.1 |
| Mean ± SD | 27.3 ± 1.1 | 26.6 ± 1.0 | −0.7 ± 0.4 |
| Maximal oxygen consumption (mL/kg−1/min−1) | |||
| #1 | 42.7 | 43.5 | 0.8 |
| #2 | 38.6 | 40.1 | 1.5 |
| #3 | 27.8 | 30.5 | 2.7 |
| #4 | 36.0 | 43.5 | 7.5 |
| Mean ± SD | 36.3 ± 5.4 | 39.4 ± 5.3 | 3.1 ± 2.6 |
| Maximal oxygen consumption (L/min−1) | |||
| #1 | 3.82 | 3.78 | −0.04 |
| #2 | 3.28 | 3.33 | 0.05 |
| #3 | 2.94 | 3.10 | 0.16 |
| #4 | 3.36 | 3.89 | 0.53 |
| Mean ± SD | 3.4 ± 0.3 | 3.5 ± 0.3 | 0.2 ± 0.2 |
Data are presented as means ± SD.
Represents significant difference (P < 0.05).
Body composition (lean)
| Pre | Post |
| |
|---|---|---|---|
| Total lean tissue mass (kg) | |||
| #1 | 72.1 | 71.2 | −0.9 |
| #2 | 58.7 | 59.6 | 0.8 |
| #3 | 74.8 | 75.3 | −0.5 |
| #4 | 64.3 | 64.2 | −0.1 |
| Mean ± SD | 67.5 ± 6.4 | 67.6 ± 6.1 | 0.1 ± 0.7 |
| Trunk lean tissue mass (kg) | |||
| #1 | 32.6 | 31.6 | −1.0 |
| #2 | 27.4 | 27.4 | 0.1 |
| #3 | 35.0 | 34.6 | 0.1 |
| #4 | 29.9 | 29.4 | −0.4 |
| Mean ± SD | 31.1 ± 2.7 | 30.8 ± 2.7 | −0.3 ± 0.4 |
| Leg lean tissue mass (kg) | |||
| #1 | 24.8 | 24.4 | −0.4 |
| #2 | 19.7 | 20.1 | 0.5 |
| #3 | 24.9 | 25.5 | 0.6 |
| #4 | 22.2 | 22.6 | 0.4 |
| Mean ± SD | 22.9 ± 2.2 | 23.2 ± 2.1 | 0.3 ± 0.4 |
| Arm lean tissue mass (kg) | |||
| #1 | 10.9 | 11.3 | −0.4 |
| #2 | 8.3 | 8.6 | 0.3 |
| #3 | 11.4 | 11.3 | −0.1 |
| #4 | 8.7 | 8.8 | 0.7 |
| Mean ± SD | 9.8 ± 1.4 | 10.0 ± 1.3 | 0.2 ± 0.2 |
Data are presented as means ± SD.
Body composition (fat)
| Pre | Post | ∆ | |
|---|---|---|---|
| Total fat mass (kg) | |||
| #1 | 13.6 | 10.9 | −2.7 |
| #2 | 23.7 | 20.4 | −3.3 |
| #3 | 27.2 | 23.3 | −3.9 |
| #4 | 25.3 | 21.9 | −3.4 |
| Mean ± SD | 22.4 ± 5.2 | 19.3 ± 4.9 | −3.3 ± 0.2 |
| Trunk fat mass (kg) | |||
| #1 | 7.4 | 5.4 | −1.9 |
| #2 | 13.4 | 11.4 | −2.0 |
| #3 | 18.4 | 15.5 | −2.9 |
| #4 | 14.7 | 12.4 | −2.3 |
| Mean ± SD | 13.5 ± 4.0 | 11.2 ± 3.7 | −2.3 ± 0.4 |
| Arm fat mass (kg) | |||
| #1 | 1.8 | 1.5 | −0.3 |
| #2 | 2.5 | 2.2 | −0.3 |
| #3 | 3.1 | 2.7 | −0.5 |
| #4 | 2.8 | 2.4 | −0.4 |
| Mean ± SD | 2.6 ± 0.5 | 2.2 ± 0.4 | −0.4 ± 0.1 |
| Leg fat mass (kg) | |||
| #1 | 3.5 | 3.0 | −0.5 |
| #2 | 6.9 | 5.9 | −1.0 |
| #3 | 4.6 | 4.4 | −0.2 |
| #4 | 6.8 | 6.1 | −0.7 |
| Mean ± SD | 5.4 ± 1.5 | 4.9 ± 1.3 | −0.6 ± 0.3 |
| Visceral fat mass (kg) | |||
| #1 | 0.6 | 0.6 | 0.0 |
| #2 | 1.1 | 0.7 | −0.4 |
| #3 | 2.0 | 1.6 | −0.4 |
| #4 | 0.8 | 0.7 | −0.1 |
| Mean ± SD | 1.1 ± 0.5 | 0.9 ± 0.4 | −0.2 ± 0.2 |
| Visceral fat volume (cm3) | |||
| #1 | 618 | 610 | −8 |
| #2 | 1182 | 790 | −392 |
| #3 | 2170 | 1684 | −486 |
| #4 | 866 | 709 | −157 |
| Mean ± SD | 1209 ± 590 | 948 ± 430 | 261 ± 188 |
Data are presented as means ± SD.
Represents significant difference (P < 0.05).
Represents a trend toward significance (P < 0.05−0.100).
Figure 2(A) Pre‐ and post‐ABEH measurements of total thigh muscle, quadricep muscle, and hamstring muscle volume via magnetic resonance imaging. Data are presented as mean±SD. (B) Representative molecular resonance images of pre‐ABEH and post‐ABEH in participant #1.
Blood lipids (n = 2)
| Pre | Post | ∆ | |
|---|---|---|---|
| Total cholesterol (mg/dL) | |||
| #1 | 176 | 193 | 17 |
| #2 | 182 | 154 | −28 |
| Mean ± SD | 179 ± 3 | 174 ± 20 | −6 ± 23 |
| LDL cholesterol (mg/dL) | |||
| #1 | 50 | 23 | −27 |
| #2 | 110 | 91 | −19 |
| Mean ± SD | 80 ± 30 | 57 ± 34 | −23 ± 4 |
| HDL cholesterol (mg/dL) | |||
| #1 | 113 | 160 | 47 |
| #2 | 38 | 49 | 11 |
| Mean ± SD | 76 ± 38 | 105 ± 56 | 29 ± 18 |
| Triglyceride (mg/dL) | |||
| #1 | 66 | 48 | −18 |
| #2 | 172 | 72 | −100 |
| Mean ± SD | 119 ± 53 | 60 ± 12 | −59 ± 41 |
| VLDL cholesterol (mg/dL) | |||
| #1 | 10 | 13 | 3 |
| #2 | 34 | 14 | −20 |
| Mean ± SD | 22 ± 12 | 14 ± 1 | −9 ± 12 |
Data are presented as means ± SD.
Represents P = 0.06.
Figure 3Individual and mean IHL as measured by magnetic resonance imaging/spectroscopy in four participants pre‐ and post‐ABEH. Units of IHL are expressed in relation to a standard of Intralipid. *Represents significant difference (P < 0.05).